Commenting on the development, Dr Vikas Gupta, Chief Executive Officer, Alkem, said, Semaglutide has the potential to change how we manage metabolic disorders
Such studies are inherently susceptible to confounding by socioeconomic status, access to healthcare, reimbursement policies, and patient adherence, all of which may significantly impact treatment continuation and metabolic outcomes
Constant Support: Continuous access to a care team reduces the anxiety of managing a complex medication alone, leading to better long-term outcomes
They provide a metabolic boost that enhances energy levels and general vitality
Desde el pasado martes, la Agencia Europea de Medicamentos (EMA) est revisando los datos disponibles sobre efectos secundarios de los frmacos Ozempic , Saxenda y Wegovy, destinados al control del peso